To examine that whether overexpression of Srxn1 would be beneficial for AP in vivo, we used AAV vector (AAV9-CMV-Srxn1-GFP, AAV-Srxn1) to introduce Srxn1 by intraductal administration (Fig. 6A). Here, SRXN1 is linked to alkaline phosphatase measurement.